The North America Drug Testing Market would witness market growth of 3.7% CAGR during the forecast period (2021-2027).
Drug abuse and addiction are considered a global issue, and millions of people are affected by this problem. According to the World Drug Report create by UNODC, in 2019; approximately 35 million people were experiencing drug use diseases around the world. Such a massive incidence of drug abuse and substance use disorders has augmented the demand & development for unique testing methods in order to prevent, manage, and treat these cases. Many leading players working in this market are launching unique and effective products to cater to the increasing demand. The growth of the global drug-testing market would be bolstered by some of the factors such as the launch of unique tests, strict regulation necessitating drug testing, and rising substance abuse & addiction.
According to the CDC estimates, approximately 13 out of 100 Americans started or increased substance abuse with an aim to manage high anxiety or emotions associated with COVID-19, thereby bolstered a massive demand for drug testing. Though, the imposition of stringent lockdown restrictions across numerous countries has hampered the demand for workplace and roadside testing in 2020, hence slowing down the growth & demand of the drug testing market.
In the North American region, many companies have included a drug test as a crucial part of the recruitment process in order to know whether their employees are not under the influence of banned drugs. The region has been experiencing a high number of cases related to drug abuse and excessive illegal consumption of drugs. In addition to it, periodic drug testing assists in ensuring that employees are not putting themselves or any of their counterparts at risk by consumption of banned substances. The majority of these organizations involve this information in their job listings so as to be transparent with applicants. In addition to these aspects, the growth & demand of drug testing in this region would be driven by the desire of the companies to ensure drug-free workplaces which are highly conducive for safety, efficiency, and overall employee happiness.
The US market dominated the North America Cocaine Drug Testing Market by Country 2020, thereby, achieving a market value of $467.5 million by 2027. The Canada market is experiencing a CAGR of 6.5% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 5.5% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Drug Testing Market is Estimated to Reach USD 11.7 Billion by 2027 at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
By Drug Type
By Sample Type
By Product Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 